精品人妻无码一区二区三区软件 ,麻豆亚洲AV成人无码久久精品,成人欧美一区二区三区视频,免费av毛片不卡无码

您現(xiàn)在的位置是:首頁(yè)技巧指導(dǎo)

研究生SCI論文真實(shí)經(jīng)歷分享

發(fā)布時(shí)間: 1

  很多研究生在校期間也會(huì)發(fā)表一些論文,論文對(duì)于一個(gè)研究生來(lái)說(shuō)作用也是非常大的。在評(píng)獎(jiǎng)學(xué)金的時(shí)候,論文也是考核要點(diǎn)之一,SCI論文更是可以加分的。學(xué)生畢業(yè)的時(shí)候也需要發(fā)表論文,各個(gè)學(xué)校對(duì)學(xué)生都有相應(yīng)的規(guī)定。有需要發(fā)表SCI論文的作者可以多和其他已經(jīng)發(fā)表過(guò)的作者交流溝通,吸取經(jīng)驗(yàn),因?yàn)镾CI論文發(fā)表的周期一般是比較長(zhǎng)的,所以在發(fā)表之前做好準(zhǔn)備,把握好各個(gè)環(huán)節(jié)的要點(diǎn)。本文小編給大家整理了研究生SCI論文投稿的真實(shí)經(jīng)歷并推薦閱讀:研究生論文幾月份投稿文章比較合適一文,分享給大家。

  我是一個(gè)二年級(jí)的研究生 以前都沒(méi)有發(fā)過(guò)論文 只是本科的時(shí)候 隨便寫(xiě)了個(gè)畢業(yè)論文(爛的很),讀了研究生遇見(jiàn)一個(gè)很有野心的老板,管你行不行統(tǒng)統(tǒng)都給我寫(xiě)英文論文,頂著巨大的壓力,我也只能硬著頭皮上了,當(dāng)然任何事情起步都很難,在新編醫(yī)藥大辭典、cnki翻譯助手、google翻譯等翻譯軟件的幫助下漸漸可以看懂英文文章,但是速度就是慢了點(diǎn)。剛好老板跟學(xué)校的一個(gè)牛人合作了一個(gè)大課題,我有材料來(lái)寫(xiě)論文了。我是學(xué)檢驗(yàn)的,課題組只能讓我們寫(xiě)寫(xiě)正常值的參考范圍(管它呢有的寫(xiě)就不錯(cuò)了,畢竟這個(gè)比較淺顯易懂)。后來(lái)我花了一個(gè)月的時(shí)間寫(xiě)好論文,個(gè)人覺(jué)得大部分還是參考別人寫(xiě)的類(lèi)似的文章的句子,然后自己稍加修改,畢竟如果都是自己寫(xiě)的話表達(dá)方面不是很好。畢竟是第一次寫(xiě),老板也是不放心,花了幾十美元找國(guó)外的網(wǎng)站修改語(yǔ)法(還是有必要的如果你對(duì)自己語(yǔ)法沒(méi)信心)。下面我就把SCI論文投稿過(guò)程的全部信件內(nèi)容貼出來(lái)(這些好多都少不了戰(zhàn)友的幫助)

  1. coverletter

  Dear Editors:

  We would like the Editorial Board of 雜志名稱(chēng) to consider our manuscript “題目”. These data have not been published elsewhere and are not being considered for publication elsewhere, in whole or in part, in any language. All authors have read and approved the submission of the manuscript.

  Thank you for your cooperation.

  Sincerely,

  作者署名

  The direct mailing address:

  第一作者

  隸屬單位Tel: Fax: Email:

  2. 在投稿被拒絕了3次了之后,終于等來(lái)了春天,一般投稿都要你,編輯來(lái)信

  The reviewers have completed examination of your above-referenced manuscript. We are pleased to inform you that it has been considered acceptable for publication in 雜志名, pending revision. The comments of the reviewers are enclosed for your guidance in revising the paper.

  We require that revised manuscript be returned to us within four weeks. We trust that you can accommodate this requirement and

  we look forward to receiving it.

  With your resubmission, please include a covering letter to explain, point by point, how you have dealt with each comment. Please the last version of the manuscript (the word processing software we use is Microsoft Word [.doc]), the conflict of interest statement and the copyright transfer.

  還有兩個(gè)審稿人的意見(jiàn)內(nèi)容太多 我就不貼出來(lái)了

  3. 我的回信

  Dear Dr. Massimo Gion:

  On behalf of my co-authors, we thank you very much for giving us an opportunity to revise our manuscript, we appreciate reviewers very much for their positive and constructive comments and suggestions on our manuscript entitled “題目”.

  We have revised the manuscript which marked in red in the paper, according to the comments and suggestions of reviewers, and responded, point by point to, the comments as listed below.

  We would like to re-submit this revised manuscript to 雜志名, and hope it is acceptable for publication in the journal. Looking forward to hearing from you soon.

  With kindest regards,

  通訊作者署名

  地址聯(lián)系方式

  下面是最重要的內(nèi)容,要提煉審稿人提出的問(wèn)題,一個(gè)個(gè)加以回答,千萬(wàn)不要漏,如果有跟審稿意見(jiàn)有沖突千萬(wàn)不要回避委婉的說(shuō)明事實(shí)及困難即可。

  Response to reviewer 1:

  1. Response to comment:The paper was written in unsatisfactory English.

  Response: We are ashamed for our unsatisfactory English and thank you very much for your cautious correction. We spent a lot of time, after we received your email, working through the paper and made some small changes marked in red in the paper to improve the English expression.Because the minor modifications are so many that we do not enumerate them.

  2. Response to comment:The paper submitted has the drawback of excluding healthy female subjects from evaluation.

  Response: Our data was derived from the Fangchenggang Area Male Healthy and Examination Survey (FAMHES) which was designed to investigate the effects of environmental and genetic factors and their interaction on the development of age-related chronic disease. But female subjects were not investigated in the project. It's a pity that our reference interval study is lack of female subjects. However, the lack of female gender investigation, as the reviewer said, is partially compensated by the fact that other authors of large and recent studies have not found a gender-related difference for AFP and CEA.

  3. Response to comment:Beneath other factors the difference in ethnic samples and determination methods as discussed by the authors may be a main reason.

  Response: The reference interval study was performed in accordance with standard operating procedures and the operational errors should be minor. Therefore the discrepancy in the results of reference interval studies is mainly due to the differences in subjects and diversities of measurements.

  4. Response to comment:Therefore it would have been helpful, if the authors had investigated this question by log-transformation of the AFP and CEA values and testing for normality by the Kolmogorov-Smirnov-test.

  Response: After log-transformation, the results of the Kolmogorov-Smirnov-test showed thatthe distribution of AFP and CEA, as you have said, conformed to a Gaussian distribution with Z=1.138 (P=0.150) and Z=0.901 (P=0.391), respectively. The parametric reference intervalswere then calculated. The content about this topic has been added in line 8, page 2, line 16, page 6, line 3, page 7 and line 3, page 9. The table II and III have also been edited. Moreover, histogram of log-AFP and log-CEA values has been added to figure 1.

  5. Response to comment:Table I-III: the abbreviations of M (mean?, median?), R (range?), Q(?)R and RI should be indicated in the heading of tables.

  Response: We are sorry for forgetting to interpret the abbreviations of M, R, QR and RI in the heading of tables and this oversight has been corrected.

  Response to reviewer 2:

  Response to comment:The relevance of this work in the clinical practice is very poor. The knowledge of precise concentrations of tumor markers in normal healthy adult for cancer screening and diagnosis is useless.

  Response: Tumor marker tests are not used alone to detect and diagnose cancer because most tumor markers can be elevated in patients who don't have a tumor. Although tumor markers are typically imperfect as screening tests to detect hidden cancers, once a particular tumor has been found with a marker, the marker may be a marvel as a means of monitoring the success (or failure) of treatment. The tumor marker level may also reflect the extent (the stage) of the disease, indicate how quickly the cancer is likely to progress and so help determine the prognosis. The acquaintance of whether the level of serum tumor maker is abnormal is based on cut-off level. Moreover, the current research about reference intervals for serum AFP and CEA is the first published report regarding Chinese populations. Therefore, this study is of great significance.

  I have rewrite “Assessment of the clinical value of serum tumor markersrequires knowledge about their precise concentrations in normal healthy adults” to “The knowledge about the cut-off level of tumor markers may help distinguish between benign and malignant disease” (line 6, page 3).

  4. 后面我又經(jīng)歷了一次小修,就不再贅述。接下來(lái)是負(fù)責(zé)排版的editor來(lái)信要確實(shí)最終的proof,及填寫(xiě)單印本訂購(gòu)單(OFFPRINT ORDER FORM)和版權(quán)轉(zhuǎn)讓表(COPYRIGHT TRANSFER FORM),問(wèn)了師兄師姐及園子里德戰(zhàn)友的意見(jiàn),大家都?jí)騿斡”究梢圆灰?如果要是要幾百歐元的,貴啊),我就直接在回信里拒絕了,COPYRIGHT TRANSFER FORM我填好以后給老板簽字,然后又掃描成pdf轉(zhuǎn)發(fā)給編輯,下面是我的回信

  Dear Sir/Madame Campori,

  Thank you for sending the galley proofs of the article to us and your kindly reminding. We have checked the galley proofs carefully including typographical errors, proper placement of pictures and tables, omissions and specific editor’s queries. We reply as follow:

  1. In the text we found in red the questions

  Response: Thank you for your reminding and we approved of all the changes after discussion. In the text, “Male Healthy and Examination Survey” should be replaced with “Male Health and Examination Survey” and the change of “The 1-sided nonparametric RIs” is OK.

  2. Fig. 1 - whether we want to have color picture?

  Response: We really apologize for having submitted the color picture. We want all the pictures to be published in black and white.

  3. The “OFFPRINT ORDER FORM”

  Response: we feel very sorry to tell you that we do not need the offprints of our paper and the offprint order form is not filled in.

  We are looking forward to publishing our article and send our best regards

  5.最后還出現(xiàn)了個(gè)小插曲,編輯回信叫我最后確認(rèn)下proof有沒(méi)有錯(cuò)誤,因?yàn)槭怯美习宓泥]箱通訊作者,結(jié)果竟然等到過(guò)了二十幾天才看到郵件(心里暗暗罵了他幾句),趕緊回信確認(rèn)并解釋?zhuān)好只是虛驚一場(chǎng)。

  Dear Sir/Madame Campori,

  We feel terribly sorry for our deferred letter.We were all immersed in the joy of the Spring Festivalin which is Chinese traditional New Year.We had a long holiday and got to a trip so as to did not see your letter in time. We have checked the final PDF and everything is ok.We deeply hope our fault does not cause you too much trouble and looking forward to publishing our article.

  Thank you

  Best regards

  署名

  最最后就是在昨天我發(fā)現(xiàn)我的文章在網(wǎng)上可以查到了(興奮啦,激動(dòng)啊),在這里要感謝曾經(jīng)幫助過(guò)我的戰(zhàn)友們,前面寫(xiě)的內(nèi)容如有不當(dāng)之處請(qǐng)指正,謝謝大家。

  有需要發(fā)表文章的作者也可以聯(lián)系本站在線編輯,給各位作者提供期刊推薦和論文指導(dǎo)等一系列服務(wù)。


文章TAG標(biāo)簽:SCI經(jīng)驗(yàn)分享

轉(zhuǎn)載請(qǐng)注明來(lái)自:http://www.jinnzone.com/jiqiaozhidao/53103.html

相關(guān)問(wèn)題答疑
sci論文作者名字上角標(biāo)a b有何區(qū)別

現(xiàn)如今發(fā)表SCI的論文的作者有很多,我相信發(fā)表過(guò)sci的作者都知道一篇論文的排序?qū)τ谧髡咧鳈?quán)有著很重要的作用,當(dāng)一篇論著出現(xiàn)多名作者的時(shí)候,在每一作者姓名右上角依次標(biāo)出阿拉伯?dāng)?shù)字1、2、3,有些雜志要求寫(xiě)英文字母a,b,c注明。那么 sci論文作者名字

發(fā)布時(shí)間:2018-11-15
成為SCI論文通訊作者須滿足哪些條件

每篇論文都會(huì)有一個(gè)通訊作者,很多人也知道,論文有第一作者,第二作者,第三作者等。一般來(lái)說(shuō),評(píng)職稱(chēng)都需要作者是第一作者,有的學(xué)校也會(huì)認(rèn)同第二作者,但是第三作者往后的基本上就不認(rèn)同了。那么什么又是通訊作者呢? 通訊作者往往指課題的總負(fù)責(zé)人,通訊

發(fā)布時(shí)間:2018-11-15
SCI論文審核通過(guò)誰(shuí)說(shuō)了算

SCI論文的學(xué)術(shù)性是非常高的,當(dāng)然,編輯審核SCI的過(guò)程也是非常嚴(yán)格的。那么一篇SCI論文如果審核通過(guò)是誰(shuí)說(shuō)了算的?下面小編給大家總結(jié)了SCI論文的一些審稿流程,各位作者也可以詳細(xì)了解一下。 1.一篇論文投到國(guó)際SCI期刊,editor(或ManagingEditor、associate

發(fā)布時(shí)間:2022-02-09
SCI論文的審稿流程是什么

SCI論文一直都是眾多學(xué)術(shù)研究者所關(guān)注的焦點(diǎn),應(yīng)該說(shuō)能成功發(fā)表一篇SCI論文對(duì)于一位學(xué)者來(lái)說(shuō)是個(gè)不小的榮譽(yù),也是對(duì)自身學(xué)術(shù)水平的肯定與認(rèn)可,在個(gè)人職業(yè)發(fā)展道路上發(fā)揮的作用也是舉足輕重的,然而,SCI論文準(zhǔn)備和發(fā)表有很大的難度,對(duì)英語(yǔ)水平有一定要求,

發(fā)布時(shí)間:2019-06-28
sci論文一篇多少錢(qián)

SCI發(fā)文章多少錢(qián)?很多作者會(huì)產(chǎn)生這樣的疑問(wèn),關(guān)于價(jià)格問(wèn)題,要看作者所投的期刊是什么,看期刊影響因子多少而決定,因此,價(jià)格并沒(méi)有完全一樣,但也無(wú)太大差距,一般SCI論文的發(fā)表價(jià)格是比較高的,上萬(wàn)元也是比較常見(jiàn)的,也正是因此,SCI論文的發(fā)表難度是相

發(fā)布時(shí)間:2017-06-02
SCI和SCIE有什么區(qū)別

SCI和SCIE有什么區(qū)別?二者乍一看只一個(gè)字母的差別,可以說(shuō)二者是不同的,但是又是有密切聯(lián)系的,在SCI刊物上發(fā)表的文章,就一定會(huì)被SCI數(shù)據(jù)庫(kù)收錄。在SCI-E上發(fā)表的文章,則選擇性收錄。首先我們要明白二者的定義,SCIE是湯姆森公司在原有的SCI文摘版源刊基

發(fā)布時(shí)間:2017-07-04
sci期刊發(fā)表要多長(zhǎng)時(shí)間

sci期刊發(fā)表要多長(zhǎng)時(shí)間 ?sci即美國(guó)《科學(xué)引文索引》的簡(jiǎn)稱(chēng),SCI(科學(xué)引文索引 )、EI(工程索引 )、ISTP(科技會(huì)議錄索引 ) 是世界著名的三大科技文獻(xiàn)檢索系統(tǒng),是國(guó)際公認(rèn)的進(jìn)行科學(xué)統(tǒng)計(jì)與科學(xué)評(píng)價(jià)的主要檢索工具,其中以SCI最為重要。sci是科學(xué)研究成果評(píng)價(jià)的

發(fā)布時(shí)間:2017-10-20
SCI和核心期刊有何區(qū)別?

SCI 等級(jí)是最高,是最難發(fā)的, 核心期刊 相對(duì)于SCI發(fā)表更加的容易,并且對(duì)于核心來(lái)說(shuō)國(guó)內(nèi)的期刊檔次要低,很多知名教授發(fā)表任何的科研的論文都會(huì)選擇SCI,畢竟這個(gè)在國(guó)際都是比較有權(quán)威的,核心期刊只是在我們國(guó)內(nèi)比較認(rèn)可,想要走上國(guó)際還得發(fā)表SCI。 SCI是

發(fā)布時(shí)間:2017-10-20
SCI論文成功發(fā)表需要經(jīng)歷哪些階段

在SCI期刊上投稿要求是非常嚴(yán)格的,因?yàn)槊總(gè)SCI期刊都對(duì)文章的質(zhì)量及格式做了很高的要求。如果需要在SCI刊物上投稿的話首先就要弄清楚雜志對(duì)文章的一些具體要求,另外還要嚴(yán)格面對(duì)文章的各個(gè)步驟。一般來(lái)說(shuō),一篇優(yōu)質(zhì)的文章需要經(jīng)歷三個(gè)階段,寫(xiě)作階段、潤(rùn)色

發(fā)布時(shí)間:2015-10-18